1. Home
  2. Analysis
  3. Prilosec
  4. Shock-haemorrhagic

Prilosec and Shock haemorrhagic - a phase IV clinical study of FDA data

Summary:

Shock haemorrhagic is reported as a side effect among people who take Prilosec (omeprazole), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Lasix, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Shock haemorrhagic when taking Prilosec. It is created by eHealthMe based on reports of 171,578 people who have side effects when taking Prilosec from the FDA, and is updated regularly.

What is Prilosec?

Prilosec has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 175,286 Prilosec users. Check the latest studies of Prilosec.

What is Shock haemorrhagic?

Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding) is found to be associated with 654 drugs and 800 conditions by eHealthMe. Check the latest studies of Shock haemorrhagic.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

171,578 people reported to have side effects when taking Prilosec.
Among them, 71 people (0.04%) have Shock haemorrhagic.

Could Prilosec cause Shock haemorrhagic?

Among these 71 people:

How long have people been on Prilosec when they have Shock haemorrhagic? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 25.0 %
  • 2 - 5 years: 12.5 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 62.5 %

What is the gender of people who have Shock haemorrhagic when taking Prilosec? *

  • female: 40.3 %
  • male: 59.7 %

What is the age of people who have Shock haemorrhagic when taking Prilosec? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 1.72 %
  • 40-49: 8.62 %
  • 50-59: 0.0 %
  • 60+: 89.66 %

What are other drugs people take besides Prilosec? *

  1. Lasix: 31 people, 43.66%
  2. Zofran: 22 people, 30.99%
  3. Oxaliplatin: 20 people, 28.17%
  4. Leucovorin Calcium: 19 people, 26.76%
  5. Xarelto: 18 people, 25.35%
  6. Fluorouracil: 17 people, 23.94%
  7. Protonix: 13 people, 18.31%
  8. Lipitor: 13 people, 18.31%
  9. Pradaxa: 12 people, 16.90%
  10. Cozaar: 11 people, 15.49%

What are other side effects people have besides Shock haemorrhagic? *

  1. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 32 people, 45.07%
  2. Anaemia (lack of blood): 26 people, 36.62%
  3. Oesophagitis (inflammation of oesophagus): 22 people, 30.99%
  4. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 20 people, 28.17%
  5. Bleeding Disorders: 16 people, 22.54%
  6. Acute Kidney Failure: 11 people, 15.49%
  7. Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 9 people, 12.68%
  8. Haemorrhagic Anaemia (anaemia due to excessive bleeding): 8 people, 11.27%
  9. Chronic Kidney Disease: 8 people, 11.27%
  10. Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 8 people, 11.27%

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 23 people, 32.39%
  2. Pain: 14 people, 19.72%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 13 people, 18.31%
  4. High Blood Pressure: 12 people, 16.90%
  5. Colon Cancer: 9 people, 12.68%
  6. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 9 people, 12.68%
  7. Stress And Anxiety: 8 people, 11.27%
  8. Infection: 8 people, 11.27%
  9. High Blood Cholesterol: 7 people, 9.86%
  10. Insomnia (sleeplessness): 7 people, 9.86%

* Approximation only. Some reports may have incomplete information.

Do you take Prilosec and have Shock haemorrhagic?

- Check whether Shock haemorrhagic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prilosec:

Shock haemorrhagic treatments and more:

How severe was Shock haemorrhagic and when was it recovered:

Expand to all the drugs that have ingredients of omeprazole:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prilosec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Shock haemorrhagic:

Browse all the conditions that are associated with Shock haemorrhagic:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on omeprazole (the active ingredients of Prilosec) and Prilosec (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.